D. Bettenhausen

The Effect of Multiple‐Dose, Oral Rifaximin on the Pharmacokinetics of Intravenous and Oral Midazolam in Healthy Volunteers

W. Forbes, H. Pentikis, C. Trapnell, 2007, Pharmacotherapy.

Absence of Effect of Oral Rifaximin on the Pharmacokinetics of Ethinyl Estradiol/Norgestimate in Healthy Females

W. Forbes, H. Pentikis, C. Trapnell, 2007, The Annals of pharmacotherapy.

Systemic pharmacokinetics of rifaximin (RFX) in subjects with shigellosis

D. N. Taylor, R. Haake, C. Trapnell, 2005 .

Recognizing and treating a new entity on the quality-of-life front: small intestinal bacterial overgrowth

C. Jahraus, D. Bettenhausen, S. Brandt, 2007 .

Prevention of acute radiation-induced proctosigmoiditis by balsalazide: a randomized, double-blind, placebo controlled trial in prostate cancer patients.

W. S. St. Clair, C. Jahraus, D. Bettenhausen, 2005, International journal of radiation oncology, biology, physics.

Inflammation's role in rectal cancer following prostate radiotherapy, and emerging evidence for a protective role for balsalazide.

D. Rubin, E. Scherl, C. Jahraus, 2005, Gastroenterology.

Evaluation and Effectiveness of a Pharmaceutical-Based Drug Information Service

Jay H. Bauman, Doug K. Bettenhausen, D. Bettenhausen, 1994 .